Using two NFAT inhibitors and AAV for Nfatc4, we found that NFATc4 signaling in the mPFC might play a role in the sustained prophylactic effects of (R)-ketamine for LPS-induced depression. The gene discussed is NFATC4; the disease is depressive symptom measurement.